RYAN SPECIALTY HOLDINGS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.0 | $2.5 | $2.0 | $1.7 | $1.4 |
| Operating income | $0.5 | $0.4 | $0.4 | $0.3 | $0.2 |
| Net income | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 |
| Balance Sheet | |||||
| Total debt | $3.4 | $3.3 | $2.0 | $2.0 | $1.6 |
| Cash Flow Statement | |||||
| Free cash flow | $0.6 | $0.5 | $0.5 | $0.3 | -$0.1 |
| Dividends | $0.1 | $0.1 | $0.0 | $0.0 | — |
| Share repurchases | — | — | $0.0 | $0.0 | $0.1 |
Shares outstanding 255.8M · Free float 43.1%
Annual filing data through FY ended December 31, 2025; float as of October 5, 2026.
Earnings
Other Coverage
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Financial Services Earnings: Demand Strong, Costs Bite Back
August 10, 2026
Filing Trends
Casualty Costs Rise as Catastrophe Pressure Eases for Insurers
June 5, 2026
Insider Signal
Concentrated Conviction in Specialty Finance and Biotech